Please login to the form below

Not currently logged in
Email:
Password:

licenses

This page shows the latest licenses news and features for those working in and with pharma, biotech and healthcare.

Global ban on pharma freebies, including cultural gifts

Global ban on pharma freebies, including cultural gifts

Implementing the new and revised Code in full is about walking the talk, about earning our license to operate.”.

Latest news

More from news
Approximately 1 fully matching, plus 395 partially matching documents found.

Latest Intelligence

  • Deal Watch October 2018

    At the end of the studies Roche has the option to license the product whereupon it will take over the responsibility for further development and commercialisation of the product.

  • Can new data aggregators shift the balance of power away from pharma? Can new data aggregators shift the balance of power away from pharma?

    How long before Google or others license the data-gathering process and apply it to other geographies where such disparate silos of data are stored.

  • Licensing

  • Pharma deals continue to slide Pharma deals continue to slide

    This month, both AstraZeneca and Lilly have entered into technology platform discovery deals with an option to license. ... It is also good to see big pharma continuing to license out projects that are no longer of interest.

  • Deal Watch - May 2017 Deal Watch - May 2017

    Are multiple regional deals better than a global deal? It is usual for big pharma to license global rights but in some cases regional deals are preferred either by the licensor

More from intelligence
Approximately 1 fully matching, plus 45 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 5 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Say Communications

Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...

Latest intelligence

The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....
Escaping the spin cycle of sub-optimal launch
...

Infographics